FR2358148A1 - Derives de 2,4-diaminopyrimidines et leur mise en solution en association avec des sulfamides - Google Patents

Derives de 2,4-diaminopyrimidines et leur mise en solution en association avec des sulfamides

Info

Publication number
FR2358148A1
FR2358148A1 FR7622162A FR7622162A FR2358148A1 FR 2358148 A1 FR2358148 A1 FR 2358148A1 FR 7622162 A FR7622162 A FR 7622162A FR 7622162 A FR7622162 A FR 7622162A FR 2358148 A1 FR2358148 A1 FR 2358148A1
Authority
FR
France
Prior art keywords
antibacterials
cpds
sodium sulphonate
useful
sulphonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7622162A
Other languages
English (en)
Other versions
FR2358148B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DICK PR
Original Assignee
DICK PR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DICK PR filed Critical DICK PR
Priority to FR7622162A priority Critical patent/FR2358148A1/fr
Publication of FR2358148A1 publication Critical patent/FR2358148A1/fr
Application granted granted Critical
Publication of FR2358148B1 publication Critical patent/FR2358148B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne la mise en solution conjointe de sulfamides et de 2,4-diaminopyrimidines dans le but d'obtenir un médicament sous la forme d'une solution aqueuse neutre stable pouvant être administrée par voie orale ou parentérale Pour ce faire, la présente invention décrit de nouveaux dérivés de 2,4-diaminopyrimidine obtenus de façon très simple qui correspondent à la formule suivante :
FR7622162A 1976-07-12 1976-07-12 Derives de 2,4-diaminopyrimidines et leur mise en solution en association avec des sulfamides Granted FR2358148A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7622162A FR2358148A1 (fr) 1976-07-12 1976-07-12 Derives de 2,4-diaminopyrimidines et leur mise en solution en association avec des sulfamides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622162A FR2358148A1 (fr) 1976-07-12 1976-07-12 Derives de 2,4-diaminopyrimidines et leur mise en solution en association avec des sulfamides

Publications (2)

Publication Number Publication Date
FR2358148A1 true FR2358148A1 (fr) 1978-02-10
FR2358148B1 FR2358148B1 (fr) 1978-12-15

Family

ID=9175931

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7622162A Granted FR2358148A1 (fr) 1976-07-12 1976-07-12 Derives de 2,4-diaminopyrimidines et leur mise en solution en association avec des sulfamides

Country Status (1)

Country Link
FR (1) FR2358148A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502152A1 (fr) * 1981-03-20 1982-09-24 Panmedica Laboratoires Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant
EP0974342A1 (fr) * 1998-07-21 2000-01-26 L'oreal Composition cosmétique aqueuse transparente à une seule phase
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US7205297B2 (en) 2000-07-24 2007-04-17 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
US7709480B2 (en) 2001-10-17 2010-05-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pyrimidine derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502152A1 (fr) * 1981-03-20 1982-09-24 Panmedica Laboratoires Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant
EP0061397A1 (fr) * 1981-03-20 1982-09-29 S.A. PANMEDICA Société dite: Nouveaux dérivés solubles N2 substitués de la diamino-2,4-benzyl-5-pyrimidines, leur procédé de préparation et médicaments les contenant
EP0974342A1 (fr) * 1998-07-21 2000-01-26 L'oreal Composition cosmétique aqueuse transparente à une seule phase
FR2781371A1 (fr) * 1998-07-21 2000-01-28 Oreal Composition cosmetique aqueuse transparente a une seule phase
JP2000044431A (ja) * 1998-07-21 2000-02-15 L'oreal Sa 単一相の透明な水性化粧品組成物
US6238681B1 (en) 1998-07-21 2001-05-29 L'oreal Single-phase transparent aqueous cosmetic composition
US6500441B2 (en) 1998-07-21 2002-12-31 L'oreal Single-phase transparent aqueous cosmetic composition
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US6916820B1 (en) 1999-04-08 2005-07-12 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US7205297B2 (en) 2000-07-24 2007-04-17 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
US7709480B2 (en) 2001-10-17 2010-05-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pyrimidine derivatives
US8420630B2 (en) 2001-10-17 2013-04-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pyrimidine derivatives

Also Published As

Publication number Publication date
FR2358148B1 (fr) 1978-12-15

Similar Documents

Publication Publication Date Title
FR2411847A1 (fr) Procede de preparation de polysaccharides presentant un degre de substitution eleve
FR2398797A1 (fr) Compositions tensioactives aqueuses concentrees
DE3762432D1 (de) Saure, pseudoplastische zusammensetzungen.
FR2358148A1 (fr) Derives de 2,4-diaminopyrimidines et leur mise en solution en association avec des sulfamides
MY117606A (en) Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids
FR2426731A1 (fr) Compositions tensio-actives aqueuses et concentrees
GB1375731A (fr)
GB985912A (en) Improvements in or relating to builders scaffolding
JPS6462302A (en) Water-soluble chitosan salt and production thereof
ES2048666A1 (es) Un preparado enzimatico estable a base de celulosas y proteasas.
FI850912A0 (fi) Foerfarande foer stabilisering av polyamider, stabiliserande kompositioner foer anvaendning vid utfoerande av foerfarandet och de erhaollna stabiliserade polyamiderna.
ES2171938T3 (es) Solucion acuosa de formiato de potasio y carbonato de potasio.
GB1300666A (en) Improvements in hull form of a full form ship
GB1252107A (fr)
GB1294938A (fr)
TR200000768T2 (tr) Alkolat içeren temizleme maddesi.
GB647912A (en) Rod and like couplings
GB1385420A (en) Preparation of 1,4-disubstituted-2-1h-quinazolinones
IE39184L (en) 9-ß-D-ARABINOFURANOSYL PURINE
GB1252665A (fr)
ES469450A1 (es) Ÿun procedimiento para la preparacion de bencilpirimidinasŸ
JPS553850A (en) Dispersant for bentonite stabilizer liquor
JPS6454097A (en) Additive for long life, high concentration coal-water slurry
GB1221447A (en) Chlorination of uracils using hypochlorites
JPS6487695A (en) Additive for long-lifetime and high-concentration coal-water slurry

Legal Events

Date Code Title Description
ST Notification of lapse
AR Application made for restoration
BR Restoration of rights
ST Notification of lapse